Skip to main content
Log in

The structure and degradation of aggrecan in human intervertebral disc

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

The ability of the intervertebral disc to resist compression is dependent on its high proteoglycan concentration. The disc proteoglycans are classified as aggregating or non-aggregating depending on their ability to interact with hyaluronan. The majority of the aggregating proteoglycans are derived from aggrecan, though their glycosaminoglycan substitution pattern has not been determined. In contrast, the origin of the non-aggregating proteoglycans is unclear, though it has been postulated that they are derived from aggrecan by proteolysis. The present work demonstrates that keratan sulfate (KS) in the glycosaminoglycan-binding region of disc aggrecan is confined to the KS-rich domain of the core protein and is not present in association with chondroitin sulfate (CS) in the CS1 and CS2 domains. It also shows that the non-aggregating disc proteoglycans are derived from aggrecan, with the large molecules possessing both the KS-rich and CS1 domains and the smaller molecules being generated from either the KS-rich or CS2 domain. The origin and spectrum of disc proteoglycan heterogeneity is the same in both the annulus fibrosus and nucleus pulposus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M, Alini M (1996) The human lumbar intervertebral disc—evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest 98:996–1003

    Article  PubMed  CAS  Google Scholar 

  2. Bayliss MT, Roughley PJ (1985) The properties of proteoglycan prepared from human articular cartilage by using associative caesium chloride gradients of high and low starting densities. Biochem J 232:111–117

    PubMed  CAS  Google Scholar 

  3. Benjamin M, Ralphs JR (2004) Biology of fibrocartilage cells. Int Rev Cytol 233:1–45

    Article  PubMed  CAS  Google Scholar 

  4. Björnsson S (1993) Size-dependent separation of proteoglycans by electrophoresis in gels of pure agarose. Anal Biochem 210:292–298

    Article  PubMed  Google Scholar 

  5. Bushell GR, Ghosh P, Taylor TFK, Akeson WH (1977) Proteoglycan chemistry of intervertebral disks. Clin Orthop 129:115–123

    PubMed  CAS  Google Scholar 

  6. Cassinelli EH, Hall RA, Kang JD (2001) Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications. Spine J 1:205–214

    Article  PubMed  CAS  Google Scholar 

  7. Doege KJ, Sasaki M, Kimura T, Yamada Y (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 266:894–902

    PubMed  CAS  Google Scholar 

  8. Goupille P, Jayson MIV, Valat JP, Freemont AJ (1998) Matrix metalloproteinases: the clue to intervertebral disc degeneration? Spine 23:1612–1626

    Article  PubMed  CAS  Google Scholar 

  9. Hascall VC (1988) Proteoglycans: the chondroitin sulfate/keratan sulfate proteoglycan of cartilage. ISI Atlas Sci Biochem 1:189–198

    CAS  Google Scholar 

  10. Hughes CE, Caterson B, White RJ, Roughley PJ, Mort JS (1992) Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. J Biol Chem 267:16011–16014

    PubMed  CAS  Google Scholar 

  11. Jahnke MR, McDevitt CA (1988) Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Biochem J 251:347–356

    PubMed  CAS  Google Scholar 

  12. Karlsson M, Edfors-Lilja I, Bjornsson S (2000) Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents. Anal Biochem 286:51–58

    Article  PubMed  CAS  Google Scholar 

  13. McDevitt CA (1988) Proteoglycans of the intervertebral disc. In: Ghosh P (ed) Biology of the intervertebral disc. CRC Press, Boca Raton, pp 151–170

    Google Scholar 

  14. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T (1986) The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur J Biochem 157:385–391

    Article  PubMed  CAS  Google Scholar 

  15. Nilsson B, De Luca S, Lohmander S, Hascall VC (1982) Structures of N-linked and O-linked oligosaccharides on proteoglycan monomer isolated from the Swarm rat chondrosarcoma. J Biol Chem 257:10920–10927

    PubMed  CAS  Google Scholar 

  16. Oegema TR (1993) Biochemistry of the intervertebral disc. Clin Sports Med 12:419–439

    PubMed  Google Scholar 

  17. Poole AR, Webber C, Reiner A, Roughley PJ (1989) Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency. Biochem J 260:849–856

    PubMed  CAS  Google Scholar 

  18. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM (2000) Matrix metalloproteinases and aggrecanase—their role in disorders of the human intervertebral disc. Spine 25:3005–3013

    Article  PubMed  CAS  Google Scholar 

  19. Roberts S, Urban JPG (2003) Degeneration of intervertebral disc. Arthritis Res Ther 5:120–130

    Article  PubMed  Google Scholar 

  20. Roughley PJ (1978) A comparative study of the glycosaminoglycan-peptides obtained after degradation of cartilage proteoglycan by different proteinases, and their use in the characterization of different proteoglycans. Connect Tissue Res 6:145–153

    Article  PubMed  CAS  Google Scholar 

  21. Roughley PJ (2004) Biology of intervertebral disc aging and degeneration—involvement of the extracellular matrix. Spine 29:2691–2699

    Article  PubMed  Google Scholar 

  22. Roughley PJ, Alini M, Antoniou J (2002) The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem Soc Trans 30:869–874

    Article  PubMed  CAS  Google Scholar 

  23. Roughley PJ, Mort JS (1986) Ageing and the aggregating proteoglycans of human articular cartilage. Clin Sci 71:337–344

    PubMed  CAS  Google Scholar 

  24. Roughley PJ, White RJ (1980) Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 255:217–224

    PubMed  CAS  Google Scholar 

  25. Roughley PJ, White RJ, Cs-Szabó G, Mort JS (1996) Changes with age in the structure of fibromodulin in human articular cartilage. Osteoarthr Cartil 4:153–161

    Article  PubMed  CAS  Google Scholar 

  26. Roughley PJ, White RJ, Magny M-C, Liu J, Pearce RH, Mort JS (1993) Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J 295:421–426

    PubMed  CAS  Google Scholar 

  27. Santer V, White RJ, Roughley PJ (1982) O-linked oligosaccharides of human articular cartilage proteoglycans. Biochim Biophys Acta 716:277–282

    PubMed  CAS  Google Scholar 

  28. Scott JE, Bosworth TR, Cribb AM, Taylor JR (1994) The chemical morphology of age-related changes in human intervertebral disc glycosaminoglycans from cervical, thoracic and lumbar nucleus pulposus and annulus fibrosus. J Anat 184:73–82

    PubMed  Google Scholar 

  29. Sztrolovics R, Alini M, Mort JS, Roughley PJ (1999) Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine 24:1765–1771

    Article  PubMed  CAS  Google Scholar 

  30. Sztrolovics R, Grover J, CS-Szabo G, Shi SL, Zhang YP, Mort JS, Roughley PJ (2002) The characterization of versican and its message in human articular cartilage and intervertebral disc. J Orthop Res 20:257–266

    Article  PubMed  Google Scholar 

  31. Tortorella MD, Liu RQ, Burn T, Newton RC, Arner E (2002) Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 21:499–511

    Article  PubMed  CAS  Google Scholar 

  32. Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, Burn T, Arner E (2000) Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J Biol Chem 275:18566–18573

    Article  PubMed  CAS  Google Scholar 

  33. Urban JPG, Roberts S, Ralphs JR (2000) The nucleus of the intervertebral disc from development to degeneration. Am Zool 40:53–61

    Article  Google Scholar 

  34. Watanabe H, Yamada Y, Kimata K (1998) Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function (Tokyo). J Biochem (Tokyo) 124:687–693

    CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by research funding from the Shriners of North America.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter J. Roughley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roughley, P.J., Melching, L.I., Heathfield, T.F. et al. The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J 15 (Suppl 3), 326–332 (2006). https://doi.org/10.1007/s00586-006-0127-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-006-0127-7

Keywords

Navigation